Pharma Mar S.A.
Develops and commercializes marine-derived oncology treatments for rare cancers.
PHM | MC
Overview
Corporate Details
- ISIN(s):
- ES0169501022 (+1 more)
- LEI:
- 959800QWKZ45ZQC2AV58
- Country:
- Spain
- Address:
- Avenida de los Reyes 1 Polígono Industrial La Mina, 28770 Colmenar Viejo
- Website:
- https://pharmamar.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Pharma Mar S.A. is an integrated biopharmaceutical company focused on the discovery, development, and commercialization of oncology treatments derived from marine sources. A pioneer in its field since 1986, the company leverages marine biodiversity to create novel therapies, with a particular focus on rare cancers. PharmaMar manages the entire drug development process, from research, supported by its extensive collection of over 500,000 marine invertebrate samples, to marketing. Its portfolio of approved anti-tumor drugs includes Yondelis® (trabectedin) for soft tissue sarcoma and ovarian cancer, Zepzelca® (lurbinectedin) for small cell lung cancer, and Aplidin® (plitidepsin) for multiple myeloma.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-09-22 00:00 |
Director's Dealing
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | ||
| 2025-06-19 00:00 |
Director's Dealing
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | ||
| 2025-06-18 00:00 |
Post-Annual General Meeting Information
Se informa que todas las propuestas de acuerdos presentadas por el Consejo a la…
|
Spanish | 389.6 KB | ||
| 2025-06-18 00:00 |
Investor Presentation
Se remite copia de la presentación a accionistas que será realizada en la Junta…
|
Spanish | 2.5 MB | ||
| 2025-06-09 00:00 |
Director's Dealing
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | ||
| 2025-06-09 00:00 |
Director's Dealing
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | ||
| 2025-06-05 00:00 |
Director's Dealing
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | ||
| 2025-05-26 17:41 |
Transaction in Own Shares
La Sociedad informa de las operaciones llevadas a cabo al amparo del Programa d…
|
Spanish | 171.3 KB | ||
| 2025-05-23 00:00 |
Director's Dealing
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | ||
| 2025-05-22 00:00 |
Director's Dealing
Motivo de la notificación: Persona Estrechamente Vinculada
|
Spanish | 91.4 KB | ||
| 2025-05-21 08:27 |
Regulatory News Service
La Sociedad presenta la solicitud en la UE para comercializar lurbinectedina en…
|
Spanish | 744.9 KB | ||
| 2025-05-19 17:40 |
Transaction in Own Shares
La Sociedad informa de las operaciones llevadas a cabo al amparo del Programa d…
|
Spanish | 183.1 KB | ||
| 2025-05-19 08:26 |
Regulatory News Service
La Sociedad anuncia que su socio Adium Pharma S.A. ha recibido la aprobación pa…
|
Spanish | 751.5 KB | ||
| 2025-05-13 00:00 |
Director's Dealing
Motivo de la notificación: Persona con Responsabilidad de Dirección
|
Spanish | 91.4 KB | ||
| 2025-05-12 17:38 |
Transaction in Own Shares
La Sociedad informa de las operaciones llevadas a cabo al amparo del Programa d…
|
Spanish | 165.2 KB |
Automate Your Workflow. Get a real-time feed of all Pharma Mar S.A. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for Pharma Mar S.A. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
